Buy Jentadueto Online

Jentadueto is an oral combination diabetes medicine that contains linagliptin and metformin hydrochloride. It is used with diet and exercise to help improve blood sugar control in adults with type 2 diabetes. When you buy Jentadueto online, choose the tablet strength shown during ordering that matches the directions from your healthcare professional.

This medicine combines two established blood sugar–lowering approaches in one tablet. Linagliptin is a DPP-4 inhibitor, a medicine that supports incretin hormones involved in insulin and glucagon balance after meals. Metformin lowers glucose production in the liver and can improve how the body responds to insulin.

Jentadueto Price, Strength Selection, and Ordering

Jentadueto price can vary by strength, quantity, and whether the product is immediate-release or extended-release. Current choices are shown during ordering, so you can match the available dose and tablet form to the directions already set by your clinician. Commonly referenced strengths include Jentadueto 2.5/500 mg and Jentadueto 2.5/1000 mg, which pair 2.5 mg linagliptin with different metformin amounts.

Some markets also use extended-release tablets, often referred to as Jentadueto XR. Searches for Jentadueto XR 2.5/1000 mg, Jentadueto XR 5/1000 mg, or linagliptin metformin XR 5/1000 mg usually reflect interest in once-daily extended-release dosing. Do not switch between immediate-release and extended-release tablets unless your healthcare professional gives specific directions, because timing and total daily metformin exposure may differ.

We provide US delivery from Canada for eligible store orders and show product choices before checkout. The cash price may matter if you are paying without insurance, so review the quantity and strength carefully before completing your purchase. For broader browsing across diabetes medicines and supplies, see our Diabetes Care category.

What Jentadueto Treats

Jentadueto is used in adults with type 2 diabetes mellitus to improve glycemic control when combined with diet and exercise. Type 2 diabetes is a chronic condition in which the body does not use insulin effectively, and over time the pancreas may not make enough insulin to keep blood glucose in range. The medicine helps lower fasting and after-meal glucose as part of a broader treatment plan.

It is not used to treat type 1 diabetes or diabetic ketoacidosis. Those conditions require different medical management and can become urgent. If you are learning how combination tablets fit into diabetes care, our Type 2 Diabetes condition information offers practical background on the condition and common treatment goals.

Many clinicians consider combination therapy when metformin alone is not enough, or when someone is already taking linagliptin and metformin separately. The goal is not simply fewer pills. The active ingredients work through different pathways, which may help support A1C reduction when the medicine is taken consistently with lifestyle measures.

How Linagliptin and Metformin Work Together

Linagliptin belongs to the DPP-4 inhibitor class. DPP-4 inhibitors help increase levels of incretin hormones, which are naturally released after meals. When blood sugar is elevated, incretin effects can increase insulin release and lower glucagon. Lower glucagon can reduce excess glucose output from the liver.

Metformin is a biguanide. It mainly reduces glucose production in the liver and may improve insulin sensitivity in muscle and other tissues. Because metformin does not directly force the pancreas to release insulin, it usually has a low risk of causing low blood sugar when used by itself.

Together, the two ingredients address complementary parts of type 2 diabetes physiology. Jentadueto can be useful for people who need more support than diet, exercise, and one agent alone. Your healthcare professional may monitor A1C, home glucose readings, kidney function, and tolerability to decide whether the combination remains a good fit.

Tablet Forms, Timing, and Use Basics

Jentadueto tablets are taken by mouth. Dosing is individualized based on current treatment, kidney function, tolerability, and glucose goals. Immediate-release tablets are commonly taken with meals, often in the morning and evening, to help reduce stomach-related side effects from metformin. Extended-release tablets are generally swallowed whole and are typically taken with an evening meal when that form is used.

Do not crush, split, or chew extended-release tablets. Damaging an extended-release tablet can change how the medicine is released into the body. If swallowing tablets is difficult, ask a healthcare professional about practical options before changing how you take the dose.

Quick tip: Keep the bottle label and your written medication schedule together so strength, timing, and meal instructions stay clear.

If a dose is missed, take it when remembered unless it is almost time for the next scheduled dose. If the next dose is close, skip the missed dose and return to the usual schedule. Do not take two doses at the same time to make up for a missed tablet.

Side Effects, Warnings, and Monitoring

Common side effects can include diarrhea, nausea, stomach upset, vomiting, headache, stuffy or runny nose, sore throat, and mild rash or itching. Metformin stomach effects are often more noticeable when treatment starts or when the dose increases. Taking tablets with food may help, but persistent symptoms should be discussed with a healthcare professional.

Serious risks are uncommon but important. Metformin-containing medicines carry a warning for lactic acidosis, a rare but potentially life-threatening buildup of lactic acid. Seek urgent care for symptoms such as unusual muscle pain, severe weakness, trouble breathing, unusual sleepiness, feeling cold, dizziness, slow or irregular heartbeat, or severe stomach symptoms with feeling unwell.

Jentadueto should not be used in people with severe kidney impairment, metabolic acidosis, or diabetic ketoacidosis. Kidney function matters because metformin is cleared by the kidneys, and reduced kidney function can raise the risk of lactic acidosis. Clinicians may check estimated glomerular filtration rate, often called eGFR, before and during treatment.

Linagliptin has been associated with pancreatitis in postmarketing reports. Contact a healthcare professional right away for severe and persistent abdominal pain, especially if it spreads to the back or occurs with vomiting. Serious allergic reactions can also occur, including swelling of the face, lips, tongue, or throat; trouble breathing; severe rash; hives; or blistering skin reactions such as bullous pemphigoid.

Low blood sugar is not usually expected from Jentadueto alone, but the risk can increase when it is combined with insulin or sulfonylureas. Symptoms may include sweating, shakiness, hunger, fast heartbeat, confusion, headache, or dizziness. Your healthcare professional may adjust other diabetes medicines if low readings occur.

Long-term metformin use may lower vitamin B12 levels in some people. Periodic blood work may be considered, especially if anemia, numbness, tingling, or neuropathy symptoms develop. Alcohol can increase the risk of lactic acidosis, so heavy alcohol use should be discussed before using metformin-containing therapy.

Interactions and Situations That Need Extra Care

Tell your healthcare professional about all medicines, supplements, and over-the-counter products you use. Carbonic anhydrase inhibitors, such as topiramate or acetazolamide, can increase the risk of metabolic acidosis when combined with metformin. Medicines that affect kidney function may also affect metformin safety.

Iodinated contrast used for certain imaging procedures can temporarily affect kidney function. Some people are told to hold metformin-containing medicines around contrast studies and restart only after kidney function is reassessed. Follow the plan given by the clinician managing the imaging procedure.

Rifampin and other strong enzyme inducers may reduce linagliptin exposure, which could affect glucose response. Diabetes treatment plans should also be reassessed during severe illness, dehydration, surgery, reduced food intake, or heavy alcohol intake. These situations can change blood sugar patterns and metformin safety.

Storage, Travel, and Handling

Store Jentadueto tablets at room temperature in the original container with the lid tightly closed. Keep the tablets away from excessive moisture, heat, and direct light. Bathrooms and kitchen counters near sinks are often poor storage areas because humidity can be high.

Keep all medicines out of reach of children and pets. For travel, carry the labeled bottle in hand luggage rather than checked baggage. Bring enough medicine for the trip plus a small buffer if possible, and keep a copy of your medication list with you.

Orders may include prompt, express shipping when that service is selected. If your package includes multiple medicines, review each item’s storage instructions after arrival. Tablets should remain in their labeled container unless your pharmacist or healthcare professional has approved another storage method.

What to Expect After Starting Treatment

Blood sugar changes usually build gradually with consistent use. Some people notice fasting readings improve first, while others see changes in after-meal patterns. A1C reflects an average over roughly three months, so clinicians often use it alongside home glucose readings to judge response.

Stomach symptoms from metformin may ease as the body adjusts, particularly when dosing is started lower and increased gradually. If diarrhea, nausea, or abdominal discomfort does not improve, ask whether timing, food intake, dose, or formulation should be reassessed. Do not stop or change the medicine without professional guidance.

Jentadueto is not considered a weight-loss medicine. Weight effects can vary, and lifestyle measures remain central to type 2 diabetes care. For education on diabetes treatment categories and practical care topics, the Type 2 Diabetes articles can help you prepare questions for your next visit.

How It Compares With Nearby Options

Jentadueto is often compared with Janumet because both combine metformin with a DPP-4 inhibitor. The difference is the DPP-4 ingredient: Jentadueto contains linagliptin, while Janumet contains sitagliptin. Both are used with diet and exercise in adults with type 2 diabetes, but kidney function, prior response, tolerability, and other medicines can influence which one is chosen.

Other diabetes combinations use different drug classes. For example, SGLT2 inhibitor and metformin combinations work partly by helping the kidneys remove glucose through urine. These may be considered for some adults, but they carry different warnings and monitoring needs. The right comparison depends on lab results, cardiovascular and kidney history, side effect risks, and glucose goals.

If source country matters for your planning, products in the Canada collection can help you browse items identified by origin. Country of origin does not replace clinical suitability; it is mainly a product-sourcing detail to review alongside strength, quantity, and cost.

Cost-Saving Considerations

Jentadueto cost without insurance depends on the strength, quantity, and current store selection. Paying cash can make the per-fill cost more visible, especially for combination diabetes medicines. Review the total amount, tablet count, and whether the product is immediate-release or extended-release before ordering.

Combination tablets may reduce the number of separate bottles, but they are not always the lowest-cost route for every person. In some cases, separate linagliptin and metformin products, a different DPP-4 combination, or another diabetes class may be considered. Ask your healthcare professional whether a lower-cost therapeutic plan could still meet your glucose goals safely.

Multi-month quantities may reduce repeat ordering effort when clinically appropriate and available. Set refill reminders before you run low, especially if you travel or rely on mail-based ordering. Avoid rationing tablets to stretch supply because inconsistent dosing can worsen glucose control.

Questions to Ask Your Healthcare Professional

• What A1C and daily glucose targets fit my health history?
• Should I use immediate-release tablets or an extended-release form?
• How often should kidney function be monitored while using metformin?
• Do any of my medicines increase low blood sugar risk?
• Which stomach symptoms are expected, and which should prompt a call?
• Should vitamin B12 be checked during long-term treatment?
• What should I do if I become dehydrated, severely ill, or need contrast imaging?

Authoritative Sources

Official DailyMed labeling for Jentadueto

Manufacturer patient information for Jentadueto

European Medicines Agency medicine information

This content is for informational purposes only and is not a substitute for professional medical advice.